Clinical Trials Sponsored by ViroMed Laboratories, Inc.

Total 385 results

Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Stanford University
Starkey Laboratories, Inc

Recruiting

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

Vertigo | Dizziness | Hearing Loss

United States
Tris Pharma, Inc.
Forest Laboratories

Completed

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

United States
Tris Pharma, Inc.
Forest Laboratories

Completed

A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol

Pharmacokinetic

United States
NuBiyota
Glycemic Index Laboratories, Inc

Completed

Safety and Efficacy of MET-3 in Obese Human Subjects

Obesity

Canada
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

Irritable Bowel Syndrome With Constipation | Chronic Idiopathic Constipation

United States
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain

Opioid-Induced Constipation

United States
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

Healthy
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome With Constipation

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition

Healthy

India
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition

Healthy

India
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Study of Milnacipran for the Treatment of Fibromyalgia

Fibromyalgia

United States
Forest Laboratories
Cypress Bioscience, Inc.

Completed

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Fibromyalgia

United States

3

Subscribe